Blackboard
   Expand   Collapse                             Search

Show details for 20142014
Hide details for 20152015
Show details for 0101
Show details for 0202
Show details for 0303
Show details for 0404
Show details for 0505
Show details for 0606
Show details for 0707
Show details for 0808
Show details for 0909
Show details for 1010
Show details for 1111
Hide details for 1212
12/22/201502:00 PMMerck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab MaceRothenberg_Pfizer.jpg Merck_Pfizer_Alliance
12/21/201510:00 AMRonastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics PM_Pigm_21122015_EMD.pdf gp_24.jpg
12/16/201505:00 PMMilliporeSigma Honored by R&D Magazine for InnovationRD_Award_Press_Release__MilliporeSigma_12162015.pdf.pdf
12/14/201510:00 AMMerck KGaA, Darmstadt, Germany, Acquires Ormet Circuits PR_Ormet_10122015_US.pdf InnovationCenter_Logo.JPG
12/14/201512:00 PMMerck KGaA, Darmstadt, Germany, Helps Refugees in LebanonPMLibanon_EMD.pdf PMLibanon.jpg
12/10/201510:00 AMMerck KGaA, Darmstadt, Germany, Confident for 2016Kley.jpg Mercrobe_man_v1.jpg PM_CMD_2015_US.pdf
12/09/201505:00 PMMerck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction CancersLucianoRossetti.jpg MaceRothenberg_Pfizer.jpg GastricPhIII_US.pdf
12/07/201507:15 AMMerck KGaA, Darmstadt, Germany, Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic CancerPancreaticCancer_1a.jpg Evo_US.pdf
Show details for 20162016
Show details for 20172017
Show details for 20182018


   Expand   Collapse                             Search

© Merck KGaA, Darmstadt, Germany